Multi-Targeting Phytochemicals for Alzheimer's Disease

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Alzheimer's disease (AD) involves β-amyloid (Aβ) and tau protein accumulation, oxidative stress, and neuroinflammation.
• Current FDA-approved AD drugs offer symptomatic relief but are not ideal for long-term use or severe disease.
• Phytochemicals are emerging as potential therapeutic agents for AD due to their diverse biological activities.

Purpose of the Study:

• To compile recent breakthroughs in Alzheimer's disease (AD) therapy utilizing phytochemicals.
• To highlight the potential of phytochemicals in halting AD progression.

Main Methods:

• Review of current literature on phytochemicals and their mechanisms against AD pathology.
• Analysis of phytochemical properties including anti-inflammatory, antioxidant, anti-amyloid, and metal-chelation effects.
• Compilation of studies investigating phytochemicals' impact on tau protein hyperphosphorylation.

Main Results:

• Phytochemicals exhibit potent anti-inflammatory and antioxidant properties relevant to AD.
• Compounds show efficacy in inhibiting Aβ aggregation and tau hyperphosphorylation.
• Several phytochemicals demonstrate metal-chelation capabilities beneficial in AD.

Conclusions:

• Phytochemicals represent a promising avenue for effective Alzheimer's disease (AD) therapy.
• Further mechanistic studies are essential to establish the clinical utility of phytochemicals in AD treatment.